Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BIAF bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Dow Jones Newswires compiled a roundup of private markets headlines and stories published on the last trading day. The package includes financing, IPO, acquisition, recall and partnership updates.
bioAffinity Technologies said it entered a definitive agreement for a registered direct offering priced at-the-market under Nasdaq rules, with concurrent private placement warrants. The company expects gross proceeds of about $4 million before fees and expenses.
bioAffinity Technologies said it entered a definitive agreement for a registered direct offering and concurrent private placement expected to raise about $4 million before fees and expenses. The company said it plans to use the net proceeds for working capital, CyPath Lung sales support and general corporate purposes.
bioAffinity Technologies, Inc. (BIAF) announced approximately $4 million in a registered direct financing of common stock, along with a concurrent private placement priced at-the-market under Nasdaq rules.